Kenvue Inc.’s shares fell after the Wall Street Journal reported that Health and Human Services Secretary Robert F. Kennedy Jr. is likely to link the company’s Tylenol painkiller to autism, though the agency said the news report was “speculation.”
The federal government is expected to release its findings on autism this month. The Journal, citing people familiar with the matter, reported Friday that it’s likely to say that use of over-the-counter pain medication with acetaminophen, which is the active ingredient in Tylenol, may cause autism.